尽管收入略有下降,但罗马尼亚生物技术公司Norofert(Norofert)在2025年提高了68%的利润,原因是成本控制、农场和国际业绩强劲。 Romanian biotech firm Norofert boosts profit 68% in H1 2025 despite slight revenue drop, citing cost control and strong farm and international performance.

罗马尼亚生物技术和有机农业投入公司Norofert报告说,2025年上半年利润增长68%,达到320万雷亚尔,尽管收入略微下降至1 900万雷亚尔。 Norofert, a Romanian biotechnology and organic agricultural inputs company, reported a 68% profit increase to RON3.2 million in the first half of 2025, despite a slight revenue decline to RON19 million. 该公司将利润提高归因于成本控制、内部生产以及Zimnicea农场和国际业务的强劲业绩。 The company attributed improved profitability to cost control, in-house production, and strong performance from its Zimnicea farm and international operations. 其股票迄今年增长率为5.4%,市场上限为6 518万雷亚尔。 Its shares rose 5.4% year-to-date, with a market cap of RON65.18 million. 其结果反映了罗马尼亚农业技术部门在更广泛的经济挑战面前的恢复力。 The results reflect resilience in Romania’s agricultural tech sector amid broader economic challenges.